DCM Shriram Fine Chemicals Ltd. Schedules Board Meeting on May 19, 2026 to Approve FY26 Financial Results
DCM Shriram Fine Chemicals Ltd. has scheduled a Board of Directors meeting for May 19, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The meeting has been intimated to BSE Ltd. and the National Stock Exchange of India Ltd. under Regulation 29 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The board will also deliberate on matters arising from the financial results, including a potential dividend declaration. The notice was filed on May 13, 2026, by Company Secretary & Compliance Officer Kokila Arora.

*this image is generated using AI for illustrative purposes only.
DCM Shriram Fine Chemicals Ltd. has informed the stock exchanges of a forthcoming Board of Directors meeting scheduled for Tuesday, May 19, 2026. The intimation was filed on May 13, 2026, pursuant to Regulation 29 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, and was addressed to both BSE Ltd. and the National Stock Exchange of India Ltd.
Board Meeting Agenda
The board meeting has been convened to consider and approve the audited financial results of the company for the quarter and financial year ended March 31, 2026, as required under Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The results will cover both standalone and consolidated financials. The board will also take up matters arising from the financial results, including a dividend declaration, if any.
Key details of the scheduled meeting are outlined below:
| Parameter: | Details |
|---|---|
| Meeting Date: | Tuesday, May 19, 2026 |
| Regulatory Provision: | Regulation 29, SEBI (LODR) Regulations, 2015 |
| Financial Results Type: | Audited Standalone & Consolidated |
| Period Under Review: | Quarter and Financial Year ended March 31, 2026 |
| Additional Agenda: | Dividend, if any |
Regulatory Compliance and Disclosure
The intimation was signed by Kokila Arora, Company Secretary & Compliance Officer (ACS 21670), on May 13, 2026. The company has stated that the notice will also be made available on its official website at www.dsfcl.com . The filing is in accordance with the disclosure obligations prescribed under SEBI listing regulations.
How does DCM Shriram Fine Chemicals' full-year FY2026 revenue and profitability compare to its FY2025 performance, and what key business segments drove growth or decline?
Will the board declare a dividend for FY2026, and if so, how might the payout ratio reflect the company's capital allocation strategy going forward?
How has DCM Shriram Fine Chemicals' stock price reacted historically following annual results announcements, and what analyst expectations are priced in ahead of the May 19 meeting?
































